Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap4.32B
Enterprise Value4.09B
P/E Ratio62.16
PEG Ratio0.44
Price/Sales Ratio3.39
Price/Book Ratio1.63
Enterprise/Revenue3.19
Enterprise/EBITDA20.36

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.05
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue783.17M
Revenue/Share3.39
Gross Profit132.48M
EBITDA127.66M
Net Income22.49M
Diluted EPS0.08

Balance Sheet

Total Cash836.03M
Total Cash/Share2.89
Total Debt395,182
Total Debt/Equity0
Current Ratio5.25
Book Value Per Share6.91

Price History

52-Week Change-35.75
52-Week High18.39
52-Week Low9.82
Moving Average 50 Days13.96
Moving Average 200 Days13.41

Statistics

Average Volume29.39M
Shares Outstanding294.68M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.89
Payout Ratio0.54
Last Split Factor3:2
Last Split DateMay 15, 2018
AD